NCT07815340 Effects Of Criteria Versus Time-Based Rehabilitation On Return To Play In Football Players
| NCT ID | NCT07815340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Hamstring Muscle Strain |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2026-09-25 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2026-09-25 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial compares criteria-based rehabilitation (CBR) with time-based rehabilitation (TBR) for football players aged 18-35 with ACL reconstruction, hamstring strain, or ankle sprain. Both groups receive a six-week supervised rehabilitation program; the progression rules differ between groups.
Eligibility Criteria
Inclusion Criteria: * Injury Type: ACL reconstruction, hamstring strain, and ankle sprain. * Rehabilitation Phase: Phase 3 for ACL injuries, Phase 1\&2 for hamstring strains and ankle sprains. * Football Activity: Active at club or regional football level Exclusion Criteria: * History of Major surgery in affected limb * Chronic neurological or musculoskeletal disorder * Non-football athletes
Contact & Investigator
Ramsha Ali
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07815340 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Hamstring Muscle Strain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07815340 currently recruiting?
Yes, NCT07815340 is actively recruiting participants. Contact the research team at saadia.batool@riphah.edu.pk for enrollment information.
Where is the NCT07815340 trial being conducted?
This trial is being conducted at Islamabad, Pakistan, Islamabad, Pakistan.
Who is sponsoring the NCT07815340 clinical trial?
NCT07815340 is sponsored by Riphah International University. The principal investigator is Ramsha Ali at Riphah International University. The trial plans to enroll 52 participants.